Supplementary Figure S1 from Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy

Supplementary Figure S1 showing correlation between CRC cell line oxaliplatin sensitivity and oxaliplatin-DNA area under the adduct curve</p

Supplementary Data from Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice

Chemical structures, patient data, mouse survival curves, additional biomarker data</p